PMPRB delay provides opportunity for meaningful consultation
June 29, 2021
IMC views Health Canada’s decision to delay implementation […]
IMC views Health Canada’s decision to delay implementation […]
On June 21, IMC submitted six recommendations […]
IMC calls on the federal government to suspend […]
Ottawa, May 6, 2021—The extraordinary development of the COVID-19 vaccines now being deployed globally is a testament to collaboration and innovation by governments, industry, and other stakeholders. Waiving TRIPS Intellectual […]
IMC welcomes the federal government’s acknowledgment in Budget 2021 […]
Statistics Canada’s new report […]
Ottawa, March 26, 2021 – Pamela Fralick, President of Innovative Medicines Canada (IMC), welcomes the Quebec budget’s emphasis on innovation, health, and economic recovery. “As a driving force for health research and […]
We are disappointed by a number of misleading statements […]
Ottawa, March 8, 2021 – Innovative Medicines Canada (IMC) issued the following statement about treatment options for COVID-19 patients. “Since the pandemic began, there has been unprecedented collaboration across governments, academia, […]
IMC issued the following statement in response to calls for the disclosure […]
